$4,500,000 FINAL CLOSING COMPRISED OF UNITS OF COMMON STOCK AND SERIES A & B WARRANTS FIRST CHINA PHARMACEUTICAL GROUP, INC.
Posted on April 18, 2011
If we get news similar to the above then you can be assured that this company is relying on toxic financing to fund their operation and interests and therefore you may as well kiss your investment goodbye if you are long. If on the other hand, we see a loan in the millions, say 15 to 20 million from an Oriental bank with a low interest rate around 3%, then you will of have done well as this will dismissed concerns about the potential of bankruptcy and therefore mark this company as Viable which in turn will create hedge funds holdings, thereby propelling the stock in an upward fashion.
